Publications Database

Aman M. G. et al. (2014)

A review of atomoxetine effects in young people with developmental disabilities.

Research in Developmental Disabilities

June, 35(6), pp. 1412-1424.

Read Abstract (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Arnold L. E. et al.

A 1.5-year follow-up of parent training and atomoxetine for attention-deficit hyperactivity disorder symptoms and noncompliant-disruptive behavior in autism.

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Arnold L. E. et al. (2006)

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

Journal of the American Academy of Child and Adolescent Psychiatry

45(10), pp. 1196-1205

Read Abstract (New Window)

Charnsil C. (2011)

Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: An open-label study.

Journal of Attention Disorders

15(8), pp. 684-689

Read Abstract (New Window)

Fernández-Jaén A. et al. (2013)

Efficacy of atomoxetine for the treatment of ADHD symptoms in patients with pervasive developmental disorders: A prospective, open-label study.

Journal of Attention Disorders

17(6), pp. 497-505.

Read Abstract (New Window)

Ghanizadeh A. (2013)

Atomoxetine for treating ADHD symptoms in autism: A systematic review.

Journal of Attention Disorders

17(8), pp. 635-640.

Read Abstract (New Window)

Golubchik P. , Sever J. , Weizman A. (2013)

Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.

Clinical Neuropharmacology

March, 36(2), pp. 37-41.

Read Abstract (New Window)

Handen B. L. et al. (2015)

Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 54(11), pp. 905-915.

Read Abstract (New Window)

Harfterkamp M. et al. (2012)

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

5(7), pp. 733-741.

Read Abstract (New Window)

Harfterkamp M. et al. (2014)

Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 481-485.

Read Abstract (New Window)

Harfterkamp M. et al. (2013)

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study.

Journal of Child and Adolescent Psychopharmacology

23(3), pp. 194-199.

Read Abstract (New Window)

Hazell P. (2007)

Drug therapy for attention-deficit hyperactivity disorder-like symptoms in autistic disorder.

Journal of Paediatrics and Child Health

43(1), pp. 19-24

Read Abstract (New Window)

Jou R. , Handen B. L. , Hardan A. Y. (2005)

Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

15(2), pp. 325-330

Read Abstract (New Window)

Lecavalier L. et al.

Parent stress in a randomized clinical trial of atomoxetine and parent training for children with autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Meer L. A. v. d. et al. (2013)

A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

Journal of Clinical Psychopharmacology

December, 33(6), pp. 824-827.

Read Abstract (New Window)

Niederhofer H. et al. (2006)

Atomoxetine treating patients with autistic disorder.

Autism

10(6), pp. 647-649

American Society of Health-System Pharmacists (2007)

Atomoxetine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Rajapakse T. , Pringsheim T. (2010)

Pharmacotherapeutics of tourette syndrome and stereotypies in autism.

Seminars in Pediatric Neurology

17(4), pp. 254-260

Read Abstract (New Window)

Reichow B. , Volkmar F. R. , Bloch M. H. (2013)

Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

43(10), pp. 2435-2441.

Read Abstract (New Window) Read Full (New Window)